Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide. The company offers a portfolio of purified SMAs for thyroid, vitamin D, cardiac, drugs of abuse, fertility, oncology, and miscellaneous indications; Pyrene 1-hydroxypyrene glucuronide (HOP-G) ELISA kit to monitor human exposure to industrial pollutants; and Pyrene (HOP-G) lateral flow kits for monitoring of at-risk individuals without laboratory equipment. It also provides contract SMAs services; and industrial and environmental biomonitoring platform, which reduces the time between sampling and results. Bioventix PLC was incorporated in 2003 and is based in Farnham, United Kingdom.
Metrics to compare | BVXP | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipBVXPPeersSector | |
---|---|---|---|---|
P/E Ratio | 20.0x | −3.2x | −0.6x | |
PEG Ratio | −6.02 | −0.03 | 0.00 | |
Price/Book | 13.5x | 2.4x | 2.6x | |
Price / LTM Sales | 11.9x | 11.3x | 3.1x | |
Upside (Analyst Target) | 59.4% | 97.0% | 55.2% | |
Fair Value Upside | Unlock | 18.2% | 9.8% | Unlock |